Novo Integrated Sciences EBITDA Margin 2012-2024 | NVOS

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Novo Integrated Sciences (NVOS) over the last 10 years. The current EBITDA margin for Novo Integrated Sciences as of February 29, 2024 is .
Novo Integrated Sciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-02-29 $0.01B $-0.01B -38.46%
2023-11-30 $0.01B $-0.00B -23.08%
2023-08-31 $0.01B $-0.00B -8.33%
2023-05-31 $0.00B $-0.02B -1600.00%
2023-02-28 $0.01B $-0.01B -108.33%
2022-11-30 $0.01B $-0.02B -125.00%
2022-08-31 $0.01B $-0.02B -133.33%
2022-05-31 $0.02B 0 0.00%
2022-02-28 $0.01B $-0.00B -18.18%
2021-11-30 $0.01B $-0.00B -30.00%
2021-08-31 $0.01B $-0.00B -22.22%
2021-05-31 $0.01B $-0.00B -50.00%
2021-02-28 $0.01B $-0.00B -57.14%
2020-11-30 $0.01B $-0.00B -42.86%
2020-08-31 $0.01B $-0.00B -37.50%
2020-05-31 $0.01B 0 0.00%
2020-02-29 $0.01B 0 0.00%
2019-11-30 $0.01B 0 0.00%
2019-08-31 $0.01B 0 0.00%
2019-05-31 $0.01B 0 0.00%
2019-02-28 $0.01B 0 0.00%
2018-11-30 $0.01B $-0.00B -12.50%
2018-08-31 $0.01B $-0.00B -12.50%
2018-05-31 $0.01B $-0.00B -37.50%
2018-02-28 $0.01B $-0.00B -37.50%
2017-08-31 $0.01B $-0.00B -33.33%
2016-11-30 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.012B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.436B 11.76
Quest Diagnostics (DGX) United States $16.207B 16.62
DaVita (DVA) United States $12.051B 14.97
Encompass Health (EHC) United States $9.224B 23.61
Chemed (CHE) United States $8.315B 25.42
Elanco Animal Health (ELAN) United States $6.375B 16.54
Option Care Health (OPCH) United States $5.413B 20.49
RadNet (RDNT) United States $4.579B 95.35
Amedisys (AMED) United States $3.211B 23.01
Astrana Health (ASTH) United States $2.923B 39.55
Addus HomeCare (ADUS) United States $2.235B 28.93
LifeStance Health (LFST) United States $2.133B 0.00
U.S Physical Therapy (USPH) United States $1.481B 39.65
Pennant (PNTG) United States $0.881B 46.52
Aveanna Healthcare Holdings (AVAH) United States $0.845B 0.00
Atai Life Sciences (ATAI) Germany $0.266B 0.00
Daxor (DXR) United States $0.044B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.020B 0.00
Ontrak (OTRK) United States $0.012B 0.00
Psychemedics (PMD) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00